Synthesis and use of glycodendrimer reagents
Abstract
The present invention relates to a chemically modified mutant protein including a cysteine residue substituted for a residue other than cysteine n a precursor protein, the substituted cysteine residue being subsequently modified by reacting the cysteine residue with a glycosylated thiosulfonate. Also a method of producing the chemically modified mutant protein is provided. The present invention also realtes to a glycosylated methanethiosulfonate. Another aspect of the present invention is a method of modifying the functional characteristics of a protein including providing a protein and reacting the protein with a glycosylated methanethiosulfonate reagent under conditions effective to produce a glycoprotein with altered functional characteristics as compared to the protein. In addition, the present invention relates to methods of determining the structure-function relationships of chemically modified mutant proteins. The present invention also relates to synthetic methods for producing thio-glycoses, the thio-glycoses so produced, and to methods for producing glycodendrimer reagents.
Claims
exact text as granted — not AI-modified1 . A chemically modified mutant protein, said mutant protein comprising a cysteine residue substituted for a residue other than cysteine in a precursor protein, the substituted cysteine residue being subsequently modified by reacting said cysteine residue with a glycosylated thiosulfonate.
2 . A method for producing a carbohydrate alkylthiosulfonate, comprising the steps of:
a) providing a carbohydrate, an alkylthiosulfonate, and a phase transfer catalyst; b) reacting said carbohydrate and said alkylthiosulfonate in an organic solvent in the presence of said phase transfer catalyst; and c) refluxing said organic solvent to produce a carbohydrate alkylthiosulfonate.
3 . The method of claim 2 , wherein said phase transfer catalyst comprises a quaternary ammonium salt.
4 . The method of claim 3 , wherein said quaternary ammonium salt is tetrabutylammonium iodide.
5 . The method of claim 2 , wherein said organic solvent comprises a non-polar organic solvent.
6 . The method of claim 5 , wherein said non-polar organic solvent comprises toluene.
7 . The method of claim 2 , wherein said alkylthiosulfonate is methanethiosulfonate.
8 . The method of claim 7 , wherein said methanethiosulfonate is a salt.
9 . The method of claim 2 , wherein said carbohydrate comprises a monosaccharide.
10 . The method of claim 9 , wherein said monosaccharide is selected from the group consisting of galactose, glucose and mannose.
11 . The method of claim 2 , wherein said carbohydrate alkylthiosulfonate is a β-anomer.
12 . The method of claim 2 , wherein said carbohydrate alkylthiosulfonate is an α-anomer.
13 . A composition of matter having the structure:
14 . A composition of matter having the structure:
15 . A composition of matter having the structure:
16 . A glycodendrimer reagent composition having the structure:
wherein a, b, c, and d are individually the same or different and are independently selected from the group consisting of integers from 0 to 10, wherein X═SR or R, and wherein R is a monosaccharide selected from the group consisting of galactose, glucose, mannose and lactose.
17 . The composition of claim 16 , wherein said monosaccharide is galactose.
18 . The composition of claim 16 , wherein said monosaccharide is glucose.
19 . The composition of claim 16 , wherein said monosaccharide is mannose.
20 . The composition of claim 16 , wherein X is
21 . The composition of claim 16 , wherein X is
22 . The composition of claim 20 , wherein a=1, b=0, c=1, and d=1.
23 . The composition of claim 21 , wherein a=1, b=0, c=1, and d=1.
24 . The composition of claim 16 , wherein a=3, b=0, c=1, d =1, X is R, and R is
25 . A glycodendrimer reagent composition having the structure:
26 . A glycodendrimer reagent composition having the structure:
27 . A method for inhibiting adhesin or lectin activity, comprising the steps of:
a) providing a modified protease, said modified protease having a thiol side chain comprising a carbohydrate moiety; b) contacting said modified protease with a composition having an adhesin or lectin activity; and c) incubating said modified protease with said composition such that the adhesin or lectin activity of said composition is inhibited.
28 . The method of claim 27 , wherein said modified protease is a modified serine protease.
29 . The method of claim 28 , wherein said modified serine protease is a modified subtilisin.
30 . The method of claim 29 , wherein said modified subtilisin is a modified Bacillus lentus subtilisin.
31 . The method of claim 28 , wherein said modified subtilisin is a modified Bacillus amyloliquefaciens subtilisin.
32 . The method of claim 27 , wherein said carbohydrate moiety comprises a monosaccharide.
33 . The method of claim 32 , wherein said monosaccharide is selected from the group consisting of glucose, mannose, and galactose.
34 . The method of claim 27 , wherein said thiol side chain is selected from the group consisting of —S-β-Glc, -Et-β-Gal, —S-Et-β-Glc, —S-Et-α-Glc, —S-Et-α-Man, —S-Et-Lac, —S-β-Glc(Ac), —S-β-Glc(AC) 2 , —S-β-Glc(Ac) 3 , —S-β-Glc(Ac) 4 , S-Et-αGlc(Ac), —S-Et -α-Glc(Ac) 2, —S-Et-α-Glc(Ac) 3 , —S-Et-α-Glc(Ac) 4 , —S-Et-β-Glc(Ac), —S-Et-β-Glc(Ac) 2 , —S-Et-β-Glc(Ac) 3 , —S-Et-β-Glc(Ac) 4 , —S-Et-α-Man(Ac), —S-Et-αMan(Ac) 2 , —S-Et-α-Man(Ac) 3 , —S-Et-α-Man(Ac) 4, —S-Et-β-Gal(Ac), —S-Et-βGal(Ac) 2 , —S-Et-β-Gal(Ac) 3 , —S-Et-β-Gal(Ac) 4 , —S-Et-Lac(Ac) 5, —S-Et-Lac(Ac) 6, —S-Et-Lac(Ac) 7 , —S-β-Gal, —S-β-Gal(Ac), —S--β-Gal(Ac) 2 , —S-βGal(Ac) 3 , —S-β-Gal(Ac) 4 , —S-β-Man, —S-β-Man(Ac), —S-β-Man(Ac) 2 , —S-β-Man(Ac) 3 , —S-β-Man(Ac) 4 , —S-α-Man, —S-α-Man(Ac), —S-α-Man(Ac) 2 , —S-α-Man(Ac) 3 , and —S-α-Man(Ac) 4 .
35 . The method of claim 27 , wherein said composition comprises an adhesin or lectin from a bacteria.
36 . The method of claim 35 , wherein said bacteria are A. naeslundii.
37 . The method of claim 30 , wherein said modified Bacillus lentus subtilisin is S156C—SS-ethyl-2-(β-D-galactopyranose).
38 . The method of claim 37 , wherein said composition comprises an adhesin or lectin from a bacteria.
39 . The method of claim 38 , wherein said bacteria are A. naeslundii.
40 . The method of claim 27 , wherein said carbohydrate, moiety is a dendrimer moiety.
41 . The method of claim 40 , wherein said modified protease is a modified serine protease.
42 . The method of claim 41 , wherein said modified serine protease is a modified subtilisin.
43 . The method of claim 42 , wherein said modified subtilisin is a modified Bacillus lentus subtilisin.
44 . The method of claim 41 , wherein said modified subtilisin is a modified Bacillus amyloliquefaciens subtilisin.
45 . The method of claim 40 , wherein said dendrimer moiety comprises mesitylene.
46 . The method of claim 43 , wherein said modified Bacillus lentus subtilisin is S156C-mes(SS-β-Gal) 2.
47 . The method of claim 46 , wherein said composition comprises an adhesin or lectin from a bacteria.
48 . The method of claim 47 , wherein said bacteria are A. naeslundii .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.